🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Immunological analysis:

Found 0 matching trials

Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow

PHASE2

RATIONALE: Sunitinib may stop the growth of tumor cells by blocking some of...

Status

Terminated

Location

Multiple Locations

Start Date

2009-02

Trial ID

NCT00824538

Treatments Being Tested

sunitinib malate flow cytometry immunohistochemistry staining method laboratory biomarker analysis

Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

PHASE2

This phase II trial studies how well ipilimumab works when given together w...

Status

Completed

Location

Rutgers Cancer Institute of New Jersey

Start Date

2012-02-06

Trial ID

NCT01498978

Treatments Being Tested

ipilimumab laboratory biomarker analysis

IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment

N/A

ABSTRACT Background The current management on rectal cancer based on TNM st...

Status

Unknown

Location

Azienda Ospedale Università di Padova

Start Date

2020-01-01

Trial ID

NCT04915326

Treatments Being Tested

rectal resection

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

N/A

RATIONALE: Collecting and storing samples of blood and tumor tissue from pa...

Status

Completed

Location

Tower Cancer Research Foundation

Start Date

2005-08

Trial ID

NCT00898508

Treatments Being Tested

gene expression analysis mutation analysis proteomic profiling reverse transcriptase-polymerase chain reaction fluorescent antibody technique immunohistochemistry staining method laboratory biomarker analysis liquid chromatography mass spectrometry medical chart review quality-of-life assessment

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

EARLY_PHASE1

RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidi...

Status

Completed

Location

Mayo Clinic

Start Date

2008-09

Trial ID

NCT00757549

Treatments Being Tested

cetuximab cisplatin TdT-mediated dUTP nick end labeling assay 3'-deoxy-3'-[18F]fluorothymidine immunohistochemistry staining method laboratory biomarker analysis fludeoxyglucose F 18 radiation therapy

Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from ...

Status

Terminated

Location

Mayo Clinic Cancer Center

Start Date

2008-07

Trial ID

NCT00700778

Treatments Being Tested

recombinant human chorionic gonadotropin microarray analysis immunohistochemistry staining method laboratory biomarker analysis needle biopsy

Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine

PHASE1

This phase I trial studies the safety and the ability to expand laboratory-...

Status

Completed

Location

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Start Date

2003-06

Trial ID

NCT00228358

Treatments Being Tested

ex vivo-expanded HER2-specific T cells cyclophosphamide denileukin diftitox flow cytometry immunoenzyme technique

Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer

N/A

RATIONALE: Collecting and storing samples of bone marrow and blood from pat...

Status

Terminated

Location

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

Start Date

2008-04

Trial ID

NCT00918658

Treatments Being Tested

biologic sample preservation procedure immunologic technique laboratory biomarker analysis

Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

PHASE2

RATIONALE: Everolimus may stop the growth of cancer cells by blocking some ...

Status

Completed

Location

Multiple Locations

Start Date

2005-03

Trial ID

NCT00618345

Treatments Being Tested

everolimus DNA analysis protein analysis western blotting flow cytometry laboratory biomarker analysis biopsy

Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.

N/A

Re-infection of the liver graft occurs universally following liver transpla...

Status

Unknown

Location

Francoise Stoll-Keller

Start Date

2003-05

Trial ID

NCT00213707

Previous Next